Protective and therapeutic effect of the Indonesian medicinal herb Curcuma xanthorrhiza on β-D-galactosamine-induced liver damage

Phytotherapy Research

Volumn 10, Issue 2, 1996, Pages 131-135

  Lin, Song Chow ^a   Teng, Chao Wei ^a   Lin, Chun Ching ^b   Lin, Yun Ho ^a   Supriyatna, S ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

D galactosamine; Curcuma xanthorrhiza; Hepatoprotective effect

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CURCUMA XANTHORRHIZA EXTRACT; GALACTOSAMINE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; HERBAL MEDICINE; HISTOPATHOLOGY; INDONESIA; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOLOGY; RAT; TRADITIONAL MEDICINE;

EID: 0029997216     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199603)10:2<131::AID-PTR786>3.0.CO;2-0     Document Type: Article

References (24)

1. Abe, H., Sakaguchi, M., Anno, M., and Arichi, S. (1981). Erythrocyte membrane stabilization by plant saponins and sapogenins. Naunyn Schmiedbergs Arch. Pharmacol. 316, 262-265.
2. Anukarahanonta, T., Shinozuka. H., and Farber, E. (1973). Inhibition of protein synthesis in rat liver by α-galactosamine. Res. Commun. Chem. Pathol. Pharmacol. 5,481-491.
3. Bachman, W., and Reutter, W. (1979). Plasma membrane of the regeneratinG rat liver. Plasma membrane as a key target organelle in gaiactosamine-induced hepatitis. Hoppe Seylers Z.Physiol. Chem. 360, 81-87.
4. Bergmeyer, H. U., Scheibe, P., and Wahlefeld, A. W. (1978). Optimization of methods for aspartate aminotransferase and alanine aminotransferase. Clin. Chem. 24, 58.
5. Chiu, H. F., Lin, C. C., Yang, C. C., and Yang, F. (1989). The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (II). Am. J. Chin. Med. 17(1-2), 17-23.
6. Decker, K., and Keppler, D. (1974). Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol. 71, 78-105.
7. Decker, K., Keppler, D., Rudigier, J., and Domschke, W. (1971). Cell damage by trapping of biosynthetic intermediates. The role of uracil nucleotides in experimental hepatitis. Hoppe Seylers Z. Phsiol. Chem. 352, 412-418.
8. DeFerreyra, E. C., DeFenos, O. M., and Castro, J. A. (1985). Late preventive effects of several anticalmodulin drugs on galactosamine-induced liver necrosis. Res. Commun. Chem. Pathol. Pharmacol. 47(2), 289-292.
9. Dumont, J. M., Maignan, M. F., and Perrissoud, D. (1987). Protective effect of maiotilate against galactosamine intoxication in the rat. Arch. Int. Pharmacodyn. Ther. 289, 269-310.
10. Farber, J. L. (1979). Reactions of the liver to injury. In Toxic Injury of the Liver, ed. by E. Farber and M. Fisher, pp. 215-241. Marcel Dekker, New York and Basel.
11. Gruen, M., Liehr, H., Gruen, W., Rasenack, U., and Branswig, D. (1974). Influence of liver-RES (reticulo-endothelial-system) on toxic liver damage due to galactosamine. Acta Hepato-Gastroenterol. 21, 5.
12. Hendrina, V. V., Jacobus, V. G., and Lambert, L. M. T. (1983). Galactosamine hepatitis, endotoxemia, and lactulose. Hepatology 3(2), 241-247.
13. Imaizumi, Y., Katoh, M., and Sugimoto, T. (1982). Effects of malotilate on the synthesis and movement of RNA in rat's liver. Folia Pharmacol. Japon. 79, 285-291. (Abstr. in English)
14. Keppler, D. (1976). Recent advances in biochemical pathology. In Toxic Liver Injury ed. by M. U. Dianzani, G. Ugazio, and L. M. Sena, p. 132. Minerva Medica, Torino.
15. Keppler, D., Lesch, R., Reutter, W., and Decker, K. (1968). Experimental hepatitis induced by D-galactosamine. Exp. Mol. Parhol. 9, 279-290.
16. Keppler, D. O. R., Rudigier, J. F. M., Bischoff, E., and Decker, F. F. A. (1970). The trapping of uridine phosphates by D-galactosamine, D-glucosamine, and 2-deoxy-D-galactose. A study on the mechanism of galactosamine hepatitis. Eur. J. Biochem. 17, 246-253.
17. Lesh, R., Reutter, W., Keppler, D., and Decker, K. (1970). Liver restitution after acute galactosamine hepatitis: autoradiographic and biochemical studies in rats. Exp. Mol. Pathol. 12, 58.
18. Leslie, Z., Anderson, W. R., and Ronald, D. (1988). Hepatic regeneratve enzyme activity after diffuse injury with galactosamine: Relationship to histologic alterations. J. Lab. Clin. Med. 112(5), 575-582.
19. Perry, M. L. (1980). Medical plants of east and south east Asia. In Properties and Uses, p. 620. MIT Press, Cambridge, USA.
20. Popper, H. (1975) Morphologic features of hepatocellular necrosis in human disease. In Pathogenesis and Mechanism of Liver Cell Necrosis, ed. by D. Keppler, pp. 15-24. MIP Press Ltd., Lancaster.
21. Purseglove, J. W., Brown, E. G., Green, C. L., and Robins, S. R. J. (1981). Spices. Vol. II. Longman, London.
22. Rasenack, J., Koch, H. K., Nowack, J., Lesch, R., and Decker, K. (1980). Hepatotoxicity of D-galactosamine in the isolated perfused rat liver. Exp. Mol. Pathol. 32, 264-275.
23. Shoji, S., Isao, K., Rumiko, T., and Haruhiro, F. (1966). The chemical studies on oriental plant drugs. XIV. The constituents of Bupleurum ssp. (1). Yakugaku Zasshi 86(12), 1132-1137.
24. Stinozuka, H., Martin, J. T., and Faber, J. L. (1973). The induction of fibrillar nucleoli in rat liver cells by D-galactosamine and their subsequent reformation into normal nucleoli. J. Ultrastruct. Res. 44, 279-292.